На главную
Результаты поиска “U.S. Pharmaceutical Sales Statistics” за 2018
The Fines That Pharmaceutical Companies Have Paid with Gwen Olsen
 
06:00
On December 2, 2004, Gwen Olsen's niece Megan committed suicide by setting herself on fire-and ended her tortured life as a victim of the adverse effects of prescription drugs. Gwen Olsen offers an honest glimpse into alarming statistics and a health care system ranked last among nineteen industrialized nations worldwide. As a former sales representative in the pharmaceutical industry for several years, Olsen learned firsthand how an unprecedented number of lethal drugs are unleashed in the United States market, but her most heartrending education into the dangers of antidepressants would come as a victim and ultimately, as a survivor. Gwen Olsen shares one woman's unforgettable journey of faith, forgiveness, and healing. Connect with The Real Truth About Health http://www.therealtruthabouthealth.com/ https://www.facebook.com/The-Real-Truth-About-Health-467500836655781/ https://twitter.com/RTAHealth Passionate believers in whole food plant based diets, no chemicals, minimal pharmaceutical drugs, no GMO's. Fighting to stop climate change and extinction.
Просмотров: 368 The Real Truth About Health
Big Pharma Cherry-Picked Study That Pushed Addiction Onto America
 
25:31
Via America’s Lawyer: Mike Papantonio discusses the factors that led to the current opioid crisis in the U.S. and speaks with attorney Jeff Gaddy about a lawsuit being brought by the Cherokee Nation against several pharmaceutical companies. Mike then talks to Natasha Alexenko, Founder of Natasha's Justice Project, about the 400,000 untested rape kits across the country. Mike is then joined by Mollye Barrows, Legal Journalist for the Trial Lawyer Magazine, to discuss the legal ramification of the Trump Administration's decision to pull out of the Paris climate accord. America's Lawyer wraps up the show by highlighting a Supreme Court victory for a Pennsylvania grandmother who had her house and vehicle seized by police. To learn more about these topics, visit http://www.levinlaw.com/america-lawyer Support us by becoming a monthly patron on Patreon, and help keep progressive media alive!: https://www.patreon.com/TheRingofFire Spread the word! LIKE and SHARE this video or leave a comment to help direct attention to the stories that matter. And SUBSCRIBE to stay connected with Ring of Fire's video content! Support Ring of Fire by subscribing to our YouTube channel: https://www.youtube.com/theringoffire Be sociable! Follow us on: Facebook: http://www.facebook.com/RingofFireRadio Twitter: http://www.twitter.com/RingofFireRadio Google+: http://plus.google.com/118415831573195648557 Instagram: https://www.instagram.com/ringoffirenetwork/ Follow more of our stories at http://www.TROFIRE.com Subscribe to our podcast: http://www.ROFPodcast.com For the last 18 months, the issue of healthcare and the behavior of the entire healthcare industry has been making headlines, whether it's Republicans trying to dismantle the few improvements that have been made to the healthcare insurance system or greedy pharma executives, price gouging, consumers. Americans are being fed a steady stream of news regarding the healthcare industry, and that's exactly what big pharma wants. The news might not always be flattering, but as long as the public is only focused on price gouging, then they aren't talking about the opioid crisis that pharma created, a crisis that's claiming the lives of tens of thousands of American citizens every single year. In 2015, there were more than 52,000 deaths in the United States attributed to drug overdose. About two thirds of those deaths came from the opioids, like OxyContin or Percocet or heroin and Fentanyl, but that's more people than died from auto accidents or firearms in the United States. Big pharma's argument is that they can't control whether or not a person overdoses on medication, but when you start to dig into the issue a little deeper, it becomes clear that the drug company executives knew this was going to happen, but they did nothing, because they knew they'd get rich off of overdoses. According to 2015, the study published in the Annual Review of Public Health, there's a direct correlation between the increases in opioid prescriptions and the increase in overdose deaths in the United States, and that's a correlation that drug company executives have known about for a very long time. To understand big pharma's role in this crisis, you have to go back to 1990's, when these opioid based painkillers were released. At the time the FDA, doctors groups, and even drug company sales reps were concerned about the addictive quality of opioid painkillers. They understood that patients could easily become addicted to painkillers and that these pills were very easy for patients to overdose on, but rather than demand that drug companies carry out extensive testing, these groups were more than happy to accept the drug companies ridiculous lies and their reassurances that their painkillers were less addictive than other opioids. That's all it took for doctors. Doctors clearly knew better, though, that one lie from drug companies, a lie that continued for more than a decade is what led hundreds of thousands of Americans to become addicted to opioid painkillers. Their doctors told them that these pills weren't addictive, because the drug companies swore to them, to the doctors, that they weren't addictive. They made it sound like there was something magic about the opioids. The drug company Purdue, who makes OxyContin had to pay out more than 600 million dollars in 2007, after a lawsuit proved that executives, lawyers, and medical officers for the company were lying, pure-out lying when they told doctors and they told the public that their pills were less addictive and more effective than other painkillers on the market.
Просмотров: 2939 The Ring of Fire
The USA Has 5% Of The Worlds Population And Uses 70% Of The World's Pharmaceuticals
 
10:47
On December 2, 2004, Gwen Olsen's niece Megan committed suicide by setting herself on fire-and ended her tortured life as a victim of the adverse effects of prescription drugs. Gwen Olsen  offers an honest glimpse into alarming statistics and a health care system ranked last among nineteen industrialized nations worldwide. As a former sales representative in the pharmaceutical industry for several years, Olsen learned firsthand how an unprecedented number of lethal drugs are unleashed in the United States market, but her most heartrending education into the dangers of antidepressants would come as a victim and ultimately, as a survivor. Gwen Olsen shares one woman's unforgettable journey of faith, forgiveness, and healing. Connect with The Real Truth About Health http://www.therealtruthabouthealth.com/ https://www.facebook.com/The-Real-Truth-About-Health-467500836655781/ https://twitter.com/RTAHealth Passionate believers in whole food plant based diets, no chemicals, minimal pharmaceutical drugs, no GMO's. Fighting to stop climate change and extinction.
Просмотров: 636 The Real Truth About Health
U.S. Drug Prices: Why Are They So High?
 
01:04:18
Americans pay more money – sometimes much more money – for prescriptions than consumers in many other wealthy countries. Why? The drivers are many and complicated. Pharmaceutical companies, employers, health care providers, patients, lawmakers, and pharmacy benefit managers all play a role. Calls to make prescriptions more affordable have prompted new efforts, including at the federal level. Last May, for example, President Trump introduced a plan intended to help reduce drug prices. This Forum event aimed to demystify the prescription drug pricing process. Experts weighed issues such as regulation, price negotiation and competitive market pressures, ultimately asking why prescription costs matter for public health. Part of The Dr. Lawrence H. and Roberta Cohn Forums, this event was presented jointly with Reuters on September 26, 2018. Watch the entire series: https://theforum.sph.harvard.edu/
Просмотров: 2042 Harvard University
US deal launches OptiBiotix's LPLDL probiotic into huge pharma space
 
08:42
Per Rehne, commercial director at OptiBiotix Health PLC (LON:OPTI), tells Proactive's Andrew Scott they've licensed out their cholesterol-lowering bacteria to an unnamed US company, which plans to use it to create a high-value pharmaceutical drug. Discussing some of the numbers involved, Rehne says Opti will receive a six-figure payment on the official signing of the agreement and two ‘milestone’ awards totalling seven figures. An additional six-figure amount, plus royalties on future sales, would be due if a product was launched. Furthermore they'll receive a seven-figure payment should the American business decide to exercise its option to broaden the licence agreement out to a global deal.
Просмотров: 847 Proactive Investors Stocktube
Teva Pharmaceuticals (TEVA) Stock: 90-second ⏲️ Investment Analysis
 
02:49
To vote for our next stock analysis, join our Private FB Group: https://SpicerCapital.com/GROUP ****** You wanna keep up with stocks, but you're busy. I understand! That's why I put together this 90-second Teva Pharmaceuticals (TEVA) stock investment analysis just for you. 🔔 Don't forget to subscribe and click the bell! SUBSCRIBE: https://SpicerCapital.com/YouTube 🕗🕘🕙 Discover 🕑🕒🕓 0:44 - TEVA Overview 0:58 - Reasons to own TEVA 1:47 - Reasons to not own TEVA 2:15 - Summary 🔗🔗🔗 Links 🔗🔗🔗 0:29 - Private Facebook Group - https://SpicerCapital.com/Group 🙌🙌🙌 Contest 🙌🙌🙌 💯 Win LIFETIME "SC Insider" access + more! 🎉🎈🥂🎊 Learn More: SpicerCapital.com/Contest 📣📣📣 More Tips and Training 📣📣📣 ✔️ https://www.Instagram.com/SpicerCapital/ ✔️ https://www.Facebook.com/SpicerCapital ✔️ https://Twitter.com/SpicerCapital ✔️ https://www.LinkedIn.com/company/Spicer-Capital/ ------------ Other Resources ------------ 📈 INSIDER - Want inside access to all my best research? Okay, here you go: https://SpicerCapital.com/INSIDER 📕 BOOK - Get your copy of "Stop Investing Like They Tell You." In stores Fall, 2018. Learn more at https://SpicerCapital.com/Book 🎧 AUDIOBOOK - Until my publisher makes me take it down... download the audiobook version of my book for FREE at https://SpicerCapital.com/SILTTY 🎓 SPICER CAPITAL UNIVERSITY - Take advantage of the free, 4-hour, gamified, video course designed to help you better protect and grow your life savings. Check it out at https://University.SpicerCapital.com 🤔 ABOUT - Learn more about me (Stephen Spicer) and Spicer Capital: https://SpicerCapital.com/About 🔎 Sources: Company 10K, 10Q, and Conference Calls Simply Wall Street - https://SpicerCapital.com/SWS (affiliate) Uncle Stock - https://SpicerCapital.com/UncleStock (affiliate) https://www.fool.com/investing/2018/02/20/6-reasons-buffett-bought-into-teva-pharmaceutical.aspx https://finance.yahoo.com/quote/TEVA/key-statistics?p=TEVA Warranties & Disclaimer Spicer Capital, LLC is a Registered Investment Advisor. This channel and information are provided for guidance and information purposes only. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial advisor and/or tax professional before implementing any strategy. This channel and information are not intended to provide investment, tax, or legal advice. Please see my full disclosures at: https://SpicerCapital.com/Disclaimer
Просмотров: 1869 Spicer Capital - Invest Smarter
Pharma Execs BUSTED Paying Millions To Doctors To Push Deadly Drugs
 
04:18
New reports show that the Bayer Healthcare Corporation paid several million dollars spread out across thousands of doctors to push their incredibly dangerous birth control called Essure. This is a very common practice with Big Pharma, and it leaves patients without an informed choice about what medications and medical devices that they put in their bodies. Ring of Fire’s Farron Cousins discusses this. For more information on the Essure lawsuits, visit https://www.levinlaw.com/essure-lawsuit-assistance-chronic-pain-tube-puncturing   Link – https://www.cnn.com/2018/07/27/health/essure-bayer-doctor-payments-eprise/index.html?no-st=1532884597   Support us by becoming a monthly patron on Patreon, and help keep progressive media alive!: https://www.patreon.com/TheRingofFire Spread the word! LIKE and SHARE this video or leave a comment to help direct attention to the stories that matter. And SUBSCRIBE to stay connected with Ring of Fire's video content! Support Ring of Fire by subscribing to our YouTube channel: https://www.youtube.com/theringoffire Be sociable! Follow us on: Facebook: http://www.facebook.com/RingofFireRadio Twitter: http://www.twitter.com/RingofFireRadio Google+: http://plus.google.com/118415831573195648557 Instagram: https://www.instagram.com/ringoffirenetwork/ Follow more of our stories at http://www.TROFIRE.com Subscribe to our podcast: http://www.ROFPodcast.com According to a bombshell new report on CNN, doctors across the country have been paid by big pharma to prescribe you dangerous medications. Specifically, this CNN expose looked at the Bayer Healthcare Corporation, and their conduct regarding their permanent birth control method called Essure. Now, what this is, it is a small metal device that is implanted into a woman's fallopian tubes, and it's supposed to stay there forever, and prevent her from ever getting pregnant. In reality, what's happening is that little metal device is breaking apart, sending little shards of metal all through women's bodies. According to some of the people interviewed for this CNN piece, it resulted in them having hysterectomies, removing the uterus and fallopian tubes, because they were all embedded with that metal, and to remove the organs was the only way to actually get the medical device out of their body. Bayer announced last week they were taking this thing off the market, but that still doesn't excuse their behavior, and the behavior of the doctors who prescribed it because they were on the dole from Bayer Healthcare Corporation. Here's what this investigation found. Between 2013 and 2017, Bayer paid $11,850, a combined two and a half million dollars, all related to that Essure permanent birth control device. Two and a half million dollars, spread out between almost 12,000 doctors. So, yeah, some doctors got a little less, maybe a few hundred dollars, maybe a few thousand. A couple of them, though, made close to 200,000. There's this one doctor, Dr. Cindy Basinski, who got $168,000.68 from Bayer, all to promote this device that they knew was faulty. They knew it was destroying the lives of women, and yet these doctors did it anyway. According to some of the women who were interviewed in this piece, their doctors actually were very pushy about forcing them to get this device. They say they were very aggressive with it. They did not want the women to know that there were other options, other possibilities. They were being paid by Bayer, and damn it, they were going to push those Bayer devices. This is not unique to Bayer and Essure. This happens every day with medications across the board. Big pharma ... And there is a phenomenal expose on ProPublica Dollars for Docs. It started several years ago, where they document all of the money that doctors take from health care organizations. You can actually go on there and look up your own doctor. But these doctors are more likely to prescribe a medication if they have been paid by that health care company. It's simple cause and effect. Just like in political campaigns, the candidate who spends the most money typically wins, the same is true with medicine. Whichever pharma company pays the doctor the most money, they're going to be the ones that win that prescription, regardless of whether or not the drug they're given, the device they're given, is going to kill or maim or disfigure that consumer. It happens every day. The worst part about all of this is, it is 100% legal. It may be unethical, but nobody's getting in trouble for this. They can't have their medical license revoked. This is something that happens daily. Big pharma's a part of it. Too many ... well, apparently thousands upon thousands of doctors in this country are a part of it, and patients never know.
Просмотров: 7705 The Ring of Fire
Halftime Report | Will 2019 be the Year of Reckoning for Sun Pharmaceuticals? | CNBC TV18
 
15:42
A glance at the Nifty Pharma index shows the wealth erosion in pharmaceutical companies has been steep. The Nifty Pharma index has lost 14% in 2018 and over 20% in the past two years with bigwig stocks such as Sun Pharmaceuticals not too far from these statistics. Sun Pharma has lost 14% of its market cap with an over 30% loss in the past two years. Like the sector, the main reasons for Sun’s underperformance is mainly two fold. CNBC-TV18 is India's No.1 Business medium and the undisputed leader in business news. The channel's benchmark coverage extends from corporate news, financial markets coverage, expert perspective on investing and management to industry verticals and beyond. CNBC-TV18 has been constantly innovating with new genres of programming that helps make business more relevant to different constituencies across India. India's most able business audience consumes CNBC-TV18 for their information & investing needs. This audience is highly diversified at one level comprising of key groups such as business leaders, professionals, retail investors, brokers and traders, intermediaries, self-employed professionals, High Net Worth individuals, students and even homemakers but shares a distinct commonality in terms of their spirit of enterprise. Subscribe to our Channel: https://goo.gl/hKwgtm Like us on Facebook: https://www.facebook.com/cnbctv18india/ Follow us on Twitter: https://twitter.com/CNBCTV18News Website: http://www.moneycontrol.com/cnbctv18/
Просмотров: 612 CNBC-TV18
Should America follow Canada's lead on legalizing marijuana?
 
03:36
Nine U.S. states currently allow recreational pot. FOX News Channel (FNC) is a 24-hour all-encompassing news service dedicated to delivering breaking news as well as political and business news. The number one network in cable, FNC has been the most watched television news channel for more than 16 years and according to a Suffolk University/USA Today poll, is the most trusted television news source in the country. Owned by 21st Century Fox, FNC is available in more than 90 million homes and dominates the cable news landscape, routinely notching the top ten programs in the genre. Subscribe to Fox News! https://bit.ly/2vBUvAS Watch more Fox News Video: http://video.foxnews.com Watch Fox News Channel Live: http://www.foxnewsgo.com/ Watch full episodes of your favorite shows The Five: http://video.foxnews.com/playlist/longform-the-five/ Special Report with Bret Baier: http://video.foxnews.com/playlist/longform-special-report/ The Story with Martha Maccallum: http://video.foxnews.com/playlist/longform-the-story-with-martha-maccallum/ Tucker Carlson Tonight http://video.foxnews.com/playlist/longform-tucker-carlson-tonight/ Hannity http://video.foxnews.com/playlist/longform-hannity/ The Ingraham Angle: http://video.foxnews.com/playlist/longform-the-ingraham-angle/ Fox News @ Night: http://video.foxnews.com/playlist/longform-fox-news-night/ Follow Fox News on Facebook: https://www.facebook.com/FoxNews/ Follow Fox News on Twitter: https://twitter.com/FoxNews/ Follow Fox News on Instagram: https://www.instagram.com/foxnews/
Просмотров: 27773 Fox News
Global Pharmaceutical Retail Market – Analysis By Type (Independent Retailers, Pharmacy Chain)
 
02:51
Globally, the market for Pharmaceutical Retail has been growing at a swift pace on the back of rising healthcare expenditure, increasing cognizance about various respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), paradigm shift of consumers towards organized players which offer high quality drugs and medicines etc. Request free Sample of this Report @ http://azothanalytics.com/report/healthcare-pharma/global-pharmaceutical-retail-market-analysis-by-type-independent-retailers-pharmacy-chain-market-share-by-region-by-country-opportunities-and-forecasts-2018-2023-r21188 http://azothanalytics.com/research/healthcare-pharma-c1 According to Azoth Analytics research report “Global Pharmaceutical Retail Market – Analysis By Type (Independent Retailers, Pharmacy Chain), Market Share, By Region, By Country: Opportunities and Forecasts (2018-2023) -- By Region (N. America, Europe, APAC, ROW), By Country (U.S., Canada, Germany, UK, India, China, Japan)” the global market is projected to display a robust growth represented by a CAGR of 4.94% during 2018 – 2023. Standalone/Independent segment has witnessed growth at a noteworthy rate over the past few years. However, Organized retail pharmacy chains is expected to witness robust growth in the forecast period due to convenient services offered which includes same-day home delivery; patient charge accounts; immunizations; compounding; and durable medical goods, maintaining health record of patient, e-prescribing in the developed nations etc. Amongst the regions, North America accounts for the largest regional share in the global Pharmaceutical Retail market in 2017. The report titled, “Global Pharmaceutical Retail Market – Analysis By Type (Independent Retailers, Pharmacy Chain), Market Share, By Region, By Country: Opportunities and Forecasts (2018-2023) -- By Region (N. America, Europe, APAC, ROW), By Country (U.S., Canada, Germany, UK, India, China, Japan)” has covered and analysed the potential of Global Pharmaceutical Retail Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global Pharmaceutical Retail market. Additionally, the report also highlights market entry strategies for various companies across the globe. A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Pharmaceutical Retail Market. The report analyzes the pharmaceutical retail market by Distribution Channel – Online retail and Offline retail. The report further assesses the global pharmaceutical retail market by independent/standalone outlets and organized chains. The global pharmaceutical market report assesses the market by Region (North America, Europe, Asia Pacific and Rest of the world) and by Country (U.S., Canada, Germany, United Kingdom, India, China, Japan)
Просмотров: 19 Azoth Analytics
How To Improve Your Sales Figures - Essential Elements Of A Sales Strategy
 
03:17
What are the elements of a sales strategy that will increase your sales in the internet age? Maybe you watched the classic movie that told you to “always be closing.” Well, I’m here to tell you that doesn’t work anymore. Most people hate being “sold to,” and can easily click away if they feel like they’re being manipulated or convinced to act against their best interests. It’s time for a new way of doing things. Have you racked your brains, wondering how to improve your sales figures? The basic elements of a sales strategy for the modern age are empathy and value. It’s time to get out of your own head. The sale isn’t about you. Few people know this, but the word “sell” comes from an Old English word meaning “to give.” In every sales conversation you give of your time, attention, and expertise. Stop worrying about how to improve your sales figures and listen to your customers. Give them the expert guidance they need to solve their problems. Your customers are hoping that you’ll be the one – don’t disappoint them. The best sales strategy is to be fully present during the conversation. Understand the customers’ frustrations and struggles. What future do they want? Connect and listen to their needs. Be clear about the value you’re offering and show that you’re the right person for them. You don’t necessarily need to spend a lot of time thinking about how to improve your sales figures. Try using your heart instead. It’s a highly effective selling technique. To design elements of a sales strategy that will work in this fast-paced high tech era you don’t need to re-invent the wheel. Just slow down, empathize with your customers, and demonstrate the value you’ll add to their lives. If you enjoyed this video, please like and subscribe to my channel. I'll be sharing videos on a regular basis going forward. To learn more about my sales training techniques check out my website http://sandyebrown.com/
Просмотров: 250 Sandye Brown
Unethical Practices Companies Use To Scam Us That Should Be (Or Are) Illegal
 
10:08
The first 1,000 people to sign up to Skillshare will get their first 2 months for free: https://skl.sh/infographics6 Unethical Practices Companies Use To Scam Us That Should Be (Or Are) Illegal SUBSCRIBE TO US -► http://bit.ly/TheInfographicsShow -------------------------------------------------------------------------- WEBSITE (SUGGEST A TOPIC): http://theinfographicsshow.com SUPPORT US: Patreon.......► https://www.patreon.com/theinfographicsshow CHAT WITH ME: DISCORD.....►https://discord.gg/theinfographicsshow SOCIAL: Twitter........► https://twitter.com/TheInfoShow Subreddit...► http://reddit.com/r/TheInfographicsShow -------------------------------------------------------------------------- Sources for this episode: Some Images used under license from Shutterstock.com
Просмотров: 382000 The Infographics Show
Free Speech & Off-Label Branding [POLICYbrief]
 
04:03
While the prescription of medicine for off-label use is legal, the FDA prohibits pharmaceutical companies from promoting these uses in any way, claiming that said companies are engaging in misbranding. Is this regulation of pharmaceutical companies by the FDA a violation of the First Amendment? Christina Sandefur of the Goldwater Institute explores the issues surrounding off-label promotion. As always, the Federalist Society takes no particular legal or public policy positions. All opinions expressed are those of the speaker. Follow Christina Sandefur on Twitter @cmsandefur https://twitter.com/cmsandefur Learn more about Christina Sandefur: https://goldwaterinstitute.org/team/christina-sandefur/ Differing Views: Regulatory Transparency Project: Off-Label Promotion and Free Speech in Medicine https://regproject.org/free-lunch-podcast-e16/ The Goldwater Institute: Restoring Free Speech in Medicine https://goldwaterinstitute.org/article/restoring-free-speech-in-medicine/ The University of Chicago Law Review: The Statutory Case Against Off-Label Promotion https://chicagounbound.uchicago.edu/uclrev_online/vol83/iss1/12/ Law Review: A Spoonful of Free Speech Helps the Medicine Go Down https://ilr.law.uiowa.edu/print/volume-99-issue-2/a-spoonful-of-free-speech-helps-the-medicine-go-down-off-label-speech-and-the-first-amendment/ Boston University Law Review: When Truth Cannot Be Presumed: The Regulation of Drug Promotion Under an Expanding First Amendment http://www.bu.edu/bulawreview/files/2014/05/ROBERTSON.pdf
Просмотров: 39607 The Federalist Society
My #1 Favorite Dividend Stock of All Time (If I Could Only Own 1 Dividend Stock)
 
25:47
Several subscribers recently asked about my favorite dividend growth stock of all time. Specifically, they asked which dividend stock I would own if I had to place all of my investment funds in one single stock. My answer is quite simple, as Johnson & Johnson (ticker: JNJ) is already the largest position in my portfolio. Today's video explains why Johnson & Johnson is my favorite stock for dividends, complete with fundamental analysis. I get started with some high level thoughts. Why do I like this stock so much? It really comes down to some high level concepts including: * Predictability (and stability) * Incredible margins (gross profit and operating) * Population trends (aging US population and growing global population) * More! Next, I dive into my Johnson & Johnson fundamental stock analysis. Specifically, I discuss concepts including: * Revenue Growth: I really enjoy how revenue is up 25% comparing 2007 and 2017. I also like how revenue tends to grow predictably on a year-by-year basis. It's like clockwork. * US versus international mix. International sales are getting close to representing 50% of this company's mix. * Incredible Margins: Gross profit is at 66.8% (wow!) and operating profit is at 23% (both from the 2017 annual report). * Dividend growth: I invest for passive income and cash flow! I need to buy companies to put cash in my pocket, cash that can be used to pay the bills. Johson & Johnson is a great example, as they've raised their dividend over 105% comparing 2017 to 2007. Despite stellar fundamentals, it looks like Johnson & Johnson has a PE ratio in the 22.94 range right now (possibly a bit lower). I backed into this number, since EPS is thrown off by one-time tax items. Certainly, the stock is priced for perfection, but it always seems to be! While I'm not buying this stock in 2018 (other than reinvesting dividends), I do want to buy more. I'm waiting for a correction, although I never expect a big one with this stock. Of course, there are a few risk factors with JNJ. I close out discussing those potential risks: * Patent expiration and the need to always innovate in their pharmaceutical division. * Overall pricing of their products (the US health care system is broken). Want to learn more about my dividend growth investing strategies? Here are a few popular videos on how I would hypnotically invest different sums of money. Getting started with $1,000: https://www.youtube.com/watch?v=Iijz-5vGSh0 Getting started with $5,000 in dividend stocks: https://www.youtube.com/watch?v=5Bp0TzQKRr0 Getting started investing with $10,000: https://www.youtube.com/watch?v=4i_3KAY1ZMo Going big with $25,000 in dividend stocks: https://www.youtube.com/watch?v=CGrf5He8ieU Investing $50,000 in income-producing securities: https://www.youtube.com/watch?v=ishEcrSTK-c Want to connect on Instagram? Please make sure to say hi! https://www.instagram.com/ianlopuch/ Disclosure: I am long Johnson & Johnson (JNJ). I own this stock in my portfolio. Disclaimer: I'm not a licensed investment advisor, and today's video is just for entertainment and fun. This video is NOT investment advice. Also, I'm not a tax advisor and today's video is NOT tax advice. Please talk to your licensed investment advisor before making any financial decisions. All content on my YouTube channel is (c) Copyright IJL Productions LLC.
Просмотров: 13805 ppcian
Webinar: Understanding Clinical Trials Data
 
17:00
Pharmaceutical companies deal with ever increasing amounts of complex data in the pursuit of creating the next life-saving drugs and biologics. Data lakes, data warehouses, and analytic solutions alone have not significantly accelerated or decreased the cost of this research. We’ll look at a different approach to handling, transforming, and analyzing data to improve insights and reduce time-to-market. Join us for a guided tour of an approach that allows stakeholders across the drug development lifecycle to create, enrich, share, and analyze data in a more flexible, cost efficient, and scalable manner. This webinar will explore: -The key problems (and broken promises) of big data in the pharmaceutical industry - How to capture and enrich the mountains of structured, semi-structured, and unstructured data in your organization - Using AI and machine learning to augment human intelligence - An example of visualizing and exploring Clinical Trials data -------- Lucidworks' Fusion platform provides the enterprise-grade capabilities needed to design, develop, and deploy intelligent search apps - at any scale. For additional tips, check out Lucidworks blog: http://lucidworks.com/blog Need advanced search capabilities now? Download Fusion: https://lucidworks.com/download/ Join an upcoming Fusion or Solr training: https://lucidworks.com/resources/solr-training-and-consulting/ Contact Sales for a free consultation: https://lucidworks.com/company/contact/
Просмотров: 94 Lucidworks
Big Food and Big Pharma killing for profit?
 
11:11
Is Big Food and Big Pharma killing for profit? How can a lifestyle intervention be more powerful than medications? And how should the medical system change, in order to empower people to revolutionize their health? For more videos: https://www.dietdoctor.com/video
Просмотров: 6631 Diet Doctor
Pharmaceutical, Medical, Medicine, Business Presentation Slide in Microsoft Office365 PowerPoint PPT
 
17:24
About this Microsoft Office PowerPoint 365 Training Video: How To Design Pharmaceutical, Medical, Doctor, Medicine, Business Presentation Slide Template in Microsoft Office 365 PowerPoint PPT. PowerPoint is an enterprise level software and an amazing product of Microsoft Office. It has a great potential and the kind of features it provides are so easy to understand and simple to use that every student, manager, marketing executive or sales guy can easily create brilliant professional presentations. Microsoft Office PowerPoint is often underestimated but it allows us to create presentations, logos, banners, templates, designs, graphics, and most importantly video animations. A PowerPoint Presentation designed appropriately can really convince your target audience. A lot of design thinking needs to be put into a slide to make sure that the message is clearly delivered to the user. I have created all the videos in PowerPoint included in Microsoft Office 365 suite. My idea is to help my audience learn the PowerPoint and get to know how easy it is to create anything in presentation. Please Subscribe to our channel: https://www.youtube.com/c/CreativeVenus/?sub_confirmation=1 You can download this professional PowerPoint template from the following Gdrive location: https://drive.google.com/open?id=10ngyv0KqyB0bKDUY1G6izlCbVJmNPK0O I have created the playlist of all the PowerPoint Training Videos. You can visit the URL: https://www.youtube.com/playlist?list=PLHq0onhvyWme0oqqKUmULNeavFY5q9C8j I hope you like this Microsoft Office 365 PowerPoint Training Video. Please Like, share, comment and subscribe to watch more such videos. Follow Us on Google Plus: https://plus.google.com/u/0/109609798992670836043 Follow Us on Twitter: https://twitter.com/creative_venus Follow Us on Facebook: https://www.facebook.com/creativevenus4u/
Просмотров: 2518 Creative Venus
BRILLIANTLY MEMORABLE: Great Gifts For Your Network Marketing Team!
 
04:54
Want more!? Check out our awesome, fun website: www.michellecunninghamonline.com Need to reach Michelle about direct sales? Email: MichelleCunninghamOnline@gmail.com Text Message Michelles Office: 860-463-5843 You can text this number 24 hours a day. We LOVE Hearing from you! Michelle Cunningham is a Direct Sales Leader with a passion for teaching YOU simple tips so YOU can have massive success! This formerly shy girl, from a broken home and humble beginnings, dreamed of a better life from a very young age. Watching her single mom struggling paycheck to paycheck, Michelle was determined to have money one day so she could afford the things the rich kids had, like Pantene shampoo and fresh apples. Paying her own way through college while waiting tables full time at Applebee’s, she landed her dream job as a pharmaceutical sales rep right out of college. At the age of 23, she attended a direct sales event and she heard you could be your own boss, become a millionaire and earn a free car. She was hooked on the idea, but her mom was convinced it was a scam! Willing to take a chance, Michelle joined direct sales just one week later, at 23 years old but, she was too nervous to tell anyone she had her own business. So she operated a secret direct sales business for six years, only selling to 5 clients, while remaining in a corporate job she dreaded every day. At 29 years old, she decided she had enough of working in a job she didn’t love. That year, she decided to make a BIG change reminding herself, “I have the power to change my life and ONLY I can do it!” She stopped making excuses for why she wouldn’t be good at direct sales and started giving herself ONLY reasons why she would be great. Living by the mantra, “Successful women feel the FEAR and do it ANYWAY,“ she challenged herself on a daily basis to step out of her comfort zone to build her business. Six months later, she was driving a free car and had become promoted to the TOP 1% of her company. Michelle believes ANYONE can make the same decision. Michelle has consistently been a top recruiter and has added over 42 individuals to her team in one month using a simple system. In addition, she is a top seller, year after year. Today, she leads a team of almost 1,000 direct sellers and is committed to their success! Last year, her amazing area sold over $3 million worth of products. Michelle attributes this success to a very simple and duplicatable system that she has created. Today, Michelle feels called to show others how to live abundant, happy lives using direct sales at the vehicle.
Просмотров: 1871 Michelle Cunningham
Sweet sweet codeine: Nigeria's cough syrup crisis - BBC Africa Eye documentary
 
52:55
In Nigeria, thousands of young people are addicted to codeine cough syrup – a medicine that’s become a street drug. The Nigerian senate estimates that 3 million bottles of codeine syrup are drunk every day in just two states – Kano and Jigawa. But who makes this syrup? And who sells it to Nigeria’s students? BBC Africa Eye went undercover to investigate. Subscribe to our channel for more investigative journalism. Nothing stays hidden forever. Subscribe: http://bit.ly/subscribetoafrica Website: https://www.bbc.com/africa Facebook: https://www.facebook.com/bbcafrica/
Просмотров: 2646041 BBC News Africa
Why to join PHARMA-STATS
 
03:10
On 5th Anniversary of PHARMA-STATS our one of the oldest student Darshak Patel shared his views from Canada.
Просмотров: 164 PHARMA -STATS
Trends in Indian Personal Care Industry
 
47:02
The talk is delivered by Mr. Jayesh Vithalani, Business Director - Personal & Home Care - South Asia Middle East, Lubrizol Advanced Materials India Pvt Ltd. At Indian Home & Personal Care Industry Market Opportunities & Challenges conference on Wednesday April 25 alongside Chemspec India / HPIC India (25-26 April 2018), Hall 1, Bombay Exhibition Centre, Mumbai. To stay tuned with further updates connect with us on: Linkedin: http://www.linkedin.com/in/chemspecindia Twitter: https://twitter.com/chemspecindia18 @chemspecindia18 Facebook: http://www.facebook.com/ChemspecIndia Website: http://www.chemspecindia.com, http://www.chemlogisticsindia.com Next Chemspec India will take place from 16-17 April 2019 at the Bombay Exhibition Centre, Mumbai. About the exhibition: Over the past decade and a half, Chemspec India has continued to develop and reinforce itself as the must-attend networking platform for both domestic and international buyers and sellers of Fine and Speciality Chemicals. Participating companies at Chemspec India represent diverse sectors of the chemical industry: Organic & Fine Chemicals, Active Pharmaceutical Ingredients (APIs), Drug Intermediates, Dyes & Pigments, Agrochemicals, Contract & Toll Manufacturing, Coatings, Cosmetic Chemicals / Ingredients, Pigments & Solvents, Surfactants, Laboratory Chemicals, and a host of Speciality Chemicals (Coating Additives, Catalysts, Enzymes etc.). It will also see a focus on Water Treatment Chemicals and the Wastewater Treatment Industry. 15th edition of Chemspec India will take place along three other co-located events. ChemProTech India 2019 – 10th International Exhibition for Chemical Processing Technology, Equipment and Supplies ChemLogistics India 2019 - 5th International Exhibition on Chemical Warehousing, Transport & Logistics HPIC India 2019 - 4th International Exhibition on Ingredients for Home, Personal & Institutional Care
Просмотров: 50 Chemspec India
Florida Sues 5 Major Drug Companies Over Opioids
 
00:33
Florida sues five major pharmaceutical companies over opioids accusing them of using deceptive marketing to boost drugs sales and misinforming and downplaying the addictive nature of the drugs.
Просмотров: 110 CBS Miami
How to use Batch Numbers with Unleashed Software
 
07:25
Reuben Sweeney demonstrates how to track use batch numbers with Unleashed in a manufacturing business. If you deal with food, beverage, cosmetics or pharmaceuticals either import, distribution, manufacture or wholesale this lesson is for you. The perishable nature of our raw materials and finished products mean we need to take extra care of the batches used in purchasing, manufacture and the finished products created. This allows us to trace our finished products right back to the batch that was produced but also to the batch numbers of the raw materials that were used in production. Batch numbers also decrease our wastage as we can better manage the expiry dates on our products. Our industry-specific mastery courses take you through getting the most out of your Unleashed by providing the best practices, tips and reports for your industry. https://www.linkacademy.com/unleashed/ We'll answer any questions you have about Inventory Management, Manufacturing, Unleashed or Xero in the comments below. If you're rather ask us in person, follow the link below to book a time that suits you straight into our calendar: https://calendly.com/link-academy-team/i-have-a-quick-question
Просмотров: 904 Link Academy
Empire Files  Death & Biostitutes   The US Opioid Crisis
 
21:57
https://www.telesurtv.net/english/news/Empire-Files-Abby-Martin-Talks-US-Opioid-Crisis-With-Mike-Papantonio-20171130-0017.html In 2016, 64,000 people died from drug overdoses in the United States, with roughly 80 percent of those deaths connected to opioids, according to a new report. The level of addiction has increased by almost 500 percent over the last six years. RELATED: Critics Say Trump's Opioid Epidemic Plan Is 'Counteractive' However, the question hanging on every concerned parent’s lips is where so many people could possible access that amount of drugs. Attorney Mike Papantonio believes the answer is as close as neighborhood clinics. In an exclusive interview with Abby Martin, the law professional — who made his name with triumphant lawsuits against big tobacco, chemical corporations and more — said he plans to take the United States' opioid crisis by the horns. Statistics show that 95 percent of suboxone sold in the world is sold in the United States and that one week of opioid use is enough to kick-start a severe addiction. With support from major distributors, pharmaceutical producers like Purdue Pharma were able to get their products into every hospital in the nation. Cleverly-crafted informative pamphlets describing addiction-free painkillers as well as pressure from federal health departments for critics was all it took to introduce dangerous substances such as Oxycodone into a patient’s daily prescription. Papantonio said that companies like Purdue are not the only corporations at fault. Major distributors like McKesson, Cardinal Health and AmerisourceBergen kept the lie alive when training new doctors. These distributors specifically targeted the nation’s poorer areas, former industrial towns with high unemployment, like Detroit, and poverty-stricken mining sectors in West Virginia. “They had done their homework and they figured out if somebody’s out of a job or somebody’s moved from the middle class to barely staying alive, that there’s despair that follows," he said, adding that investigations show that these sections are booming with distributors. The lawyer pointed to the growing number of sales, saying that in a town with a population of three million, distributors might sell as many as 700 million opioids. The addiction rate in these lower-class sectors has rocketed, transforming what began as a US$500 billion company into a US$500 billion industry almost overnight. “What they did, is they made this addiction issue part of their business plan,” Papantonio said. "They internalized what was happening out there on the street to become part of their business." He added that opioids then become a gateway drug for heroin. The pattern between former distribution hubs and spikes in heroin overdose admittances provide ample proof. “People ask me all the time, ‘Well, is this bigger than tobacco?’ This is much bigger than tobacco. This targeted our children,” Papantonio said. Although medical professionals are now taking action, the damage has already been done and only taking down these major corporations will make a difference for future generations, he added. RELATED: Cherokee Nation Sues Drug Firms over Opioid Crisis “My goal and what I’m doing nationally, I want to get all these cities and states, I want to get their money back for them, but I really want to make sure that some of them (corporate leaders) go to prison.” Papantonio explained that if they’re caught, the only regulation in place able to punish a corporation is the 1970s-era Substance Act, which only requires companies pay a fine for misdemeanors. Frequently, however, these same corporations will turn around and write off the fine as a business expense, leaving the federal government and taxpayers to “flip the bill.” The attorney said he’s hoping to take these companies to court with separate cases for each entity, adding that unlike other lawyers before him, he has no intention of settling. In the past, attorney generals have walked away from their cases after a US$50-$100 million settlement, a menial sum to a major corporation. “Yeah, they wear Armani suits and they have Rolex watches and they drive Bentley’s around. They come from great schools and live in Hamptons, and so we don’t look at them like criminals, so we don’t put them in prison.”
Просмотров: 304 Questioning Everything to Find Truth
Inkjet Test Printing- BAGS, Pails, Labels, Handheld Inkjet REINER...
 
08:01
https://shop.neumannmarking.com/collections/reiner Reiner JetStamp 790MP is very unique and useful Handheld Inkjet Printer. Used for marking Lot numbers, Batch numbers, Expiry Dates, Best Before dates on Food and Beverage Packaging, Pharmaceutical Packaging, Health and Beauty Packaging etc. Leave us a comment if you'd like Test Prints on your products. https://shop.neumannmarking.com/collections/reiner
Amazon beats flipkart & becomes India's largest e-commerce company by gross sales
 
01:38
In what signals a intense war in the e-commerce space, Amazon has overtaken Flipkart in GMV sales for the first time. Barclays report says Amazon generated sales of $7.5 bn compared to $6.2 bn of Flipkart. Rahul Dayama decodes the numbers for the story. Subscribe To ET Now For Latest Updates On Stocks, Business, Trading | ► https://goo.gl/SEjvK3 Subscribe Now To Our Network Channels :- Times Now : http://goo.gl/U9ibPb The NewsHour Debate : http://goo.gl/LfNgFF To Stay Updated Download the Times Now App :- Android Google Play : https://goo.gl/zJhWjC Apple App Store : https://goo.gl/d7QBQZ Social Media Links :- Twitter - http://goo.gl/hA0vDt Facebook - http://goo.gl/5Lr4mC G+ - http://goo.gl/hYxrmj Website - www.etnownews.com
Просмотров: 432 ET NOW
Spotlight interview: Christi Shaw, President, Lilly Biomedicines
 
02:30
Christi Shaw, President at Lilly Biomedicines speaking to eyeforpharma about what inspires her and how she sees pharma needing to change. eyeforpharma’s youtube channel now broadcasts the best presentations, chats and interviews from our conferences. eyeforpharma’s mission is to make the pharmaceutical industry more open and valued. Our conferences are where leading minds gather to discuss and share strategies that drive value for patients and shine a light on pharma excellence. Look for talks on patient-centricity, multi-channel marketing, value-added services, real-world data and sales force effectiveness. Get the latest industry insights in your inbox: http://social.eyeforpharma.com/ Follow eyeforpharma on Twitter: http://www.twitter.com/eyeforpharma Like eyeforpharma on Facebook: http://www.facebook.com/eyeforpharma Subscribe to our channel: http://www.youtube.com/user/eyeforpharma
Просмотров: 177 eyeforpharma
Johnson & Johnson’s Earnings: What's this Company's Secret?
 
11:12
Johnson & Johnson (NYSE: JNJ) is a healthcare Goliath that generates billions of dollars in revenue from consumer goods, pharmaceuticals, and medical devices. In the third-quarter, the company’s sales of those products allowed it to outpace analyst estimates. Can J&J continue to reward investors with upside? In this clip from The Motley Fool's Industry Focus: Healthcare, analyst Shannon Jones and Motley Fool contributor Todd Campbell discuss J&J’s impressive performance, how oncology drugs are moving the needle, and the one big risk that could dent sales in 2019. ------------------------------------------------------------------------ Subscribe to The Motley Fool's YouTube Channel: http://www.youtube.com/TheMotleyFool Or, follow our Google+ page: https://plus.google.com/+MotleyFool/posts Inside The Motley Fool: Check out our Culture Blog! http://culture.fool.com Join our Facebook community: https://www.facebook.com/themotleyfool Follow The Motley Fool on Twitter: https://twitter.com/themotleyfool
Просмотров: 632 The Motley Fool
Opioid Nation: An American Epidemic
 
58:50
Opioid Nation: An American Epidemic
Просмотров: 684 KPRC 2 Click2Houston
Spreadsheet Validation for Data Integrity
 
03:41
Concept of Spreadsheet Validation for Data Integrity - Specifically for Pharmaceutical Research in compliance with 21 CFR Part 211. For Bioanalytical, Analytical, Validation, Quality Control, Stability and many ofhers. Contact us on inquiry.pharsoft@gmail.com to get free demo spreadsheets with lots of features.
Просмотров: 114 PharSoft Research Solutions
Stocks to buy: NIO Inc. (NYSE: NIO)
 
03:00
Stocks to buy: NIO Inc. (NYSE: NIO) - RICH TV LIVE - September 13, 2018 - NIO Inc. Announces Pricing Of Initial Public Offering GlobeNewswire - Wed Sep 12, 3:46AM CDT NIO Inc. ("NIO" or the "Company") (NYSE:NIO), a pioneer in China's premium electric vehicle market, today announced the pricing of its initial public offering of 160,000,000 American depositary shares ("ADSs") at a price to the public of US$6.26 per ADS for a total offering size of approximately US$1.0 billion, assuming the underwriters do not exercise their option to purchase additional ADSs. Each ADS represents one Class A ordinary share of the Company. The ADSs are expected to begin trading on the New York Stock Exchange on September 12, 2018 under the symbol "NIO." The offering is expected to close on September 14, 2018, subject to customary closing conditions. The Company has granted the underwriters an option, exercisable within 30 days from the date of the final prospectus, to purchase up to an aggregate of 24,000,000 additional ADSs to cover over-allotments. Morgan Stanley & Co. LLC, Goldman Sachs (Asia) L.L.C., J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated, Deutsche Bank Securities, Citigroup Global Markets Inc., Credit Suisse Securities (USA) LLC, UBS Securities LLC and Wolfe Capital Markets and Advisory are acting as joint underwriters of this offering. Subscribe - https://www.youtube.com/c/RICHTVLIVE Visit - http://www.richtvlive.com/ a one-stop shop for cryptocurrency, stocks, sports, travel and trending topics. #richtvlive #stocks #news Join the Conversation get the RICH TV LIVE app at Google Play - https://play.google.com/store/apps/details?id=com.app.richtvlive iPhone App Store - https://itunes.apple.com/us/app/richtvlive/id1212158240?Is=1&mt=8 Popular Uploads - https://goo.gl/tbvXGg Most Recent Upload - https://goo.gl/unKXBy YouTube Channel Page - https://goo.gl/yUdG7w Subscribe - https://goo.gl/q2tLnn Rich TV Live Playlist - https://goo.gl/e116JF YouTube support Tubebuddy - https://www.tubebuddy.com/RICHTVLIVE Disclaimer Rich TV's company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in Rich TV reports company profiles or other investor relations materials and presentations are subject to change. Rich TV and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time. Investing is inherently risky. Rich TV is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles or in other investor relations materials or presentations that it publishes electronically or in print. We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov.
Просмотров: 3685 RICH TV LIVE
Torrent Pharmaceuticals Ltd Investors Conference Call Qtr1 FY19
 
59:06
Torrent Pharmaceuticals ltd. Management answering questions from Investors and Financial Analysts after declaring their quarterly results in their latest Earnings call. Tap into the wisdom of the large investing network and empower yourself to make smarter and well informed investment decisions. Visit http://www.stockadda.com To hear all companies concalls (Searchable & Updated before posting here) visit http://www.stockadda.com/concalls Please Submit Concall recordings, Concall transcripts, Company presentations & Management Interviews on: http://www.stockadda.com/concalls/submit Your contribution would help the Indian Investor community. View, Give & Track Stock Ideas: http://www.stockadda.com/stock-ideas Asia’s First Trading Virtual Summit (September 10-16, 2018), Claim your free attendance pass: https://rplg.co/e6ffd1d0 #stockmarket #investing #concall #EarningCalls #investors #QuarterlyResults #interview #TorrentPharmaceuticals
Просмотров: 181 Stockadda
Katherine Eban on The Open Mind: The Helpless U.S. in the Global Pervasiveness of Fraudulent Drugs
 
27:38
On this week's episode of The Open Mind, investigative reporter Katherine Eban discusses pharmaceutical counterfeiting. Eban uncovered the comprehensive picture of how under-policed generic companies operate for Fortune Magazine. As she writes, “It’s not a tale of cutting corners or lax manufacturing practices, but one of outright fraud in which the company knowingly sells substandard drugs around the world including in the US, while working to deceive regulators.” Watch on PBS: http://www.pbs.org/show/open-mind/ Watch on Thirteen.org: https://www.thirteen.org/openmind/science/the-real-drug-crisis/5943/ Follow The Open Mind on Twitter: https://twitter.com/OpenMindTV Follow Katherine Eban on Twitter: https://twitter.com/KatherineEban Follow Alexander Heffner on Twitter: https://twitter.com/heffnera In this episode of The Open Mind, we discuss how the high cost of medication in the United States has led us into the arms of foreign powers to produce low-cost generic drugs. Big Pharma companies have become experts in how to fraudulently market drugs and alter data in manufacturing labs. Yet, top executives are not put in jail. The FDA, originally set up as a domestic agency, finds itself tasked with becoming a global policeman of foreign manufacturing plants. Ill-equipped for this responsibility, overseas manufacturing plants often end up fooling the FDA to gain approval for drugs that don’t actually work. While the impact on patients will likely never be known, it’s clear that millions of people worldwide got medicine of dubious quality. What do we need to do to start tackling worldwide drug counterfeiting? Eban argues that the United States can start by regulating drug prices to take some of the profit and heat out of the pharma marketplace, releasing us from the arms of low-cost drug makers in developing countries like India and China. Bringing drug production back to the United States can be pricey, but Eban believes we are a couple of scandals away from widespread awareness in terms of drug pricing. Eban suggests that we need a consumer revolution to spark change, and stresses the importance of remaining persistent throughout our unusual news cycles, holding onto and pushing through important issues.
Просмотров: 8634 The Open Mind
CHILEAN ARMED FORCES EXPRESSES INTEREST IN BUYING BRAHMOS MISSILES
 
03:56
Anita Nayar, Indian ambassador to Chile told FE Online that, “The choice of Chile for the conclave is very strategic. It is also a signal that Indian businesses are looking towards Chile and vice versa.” In an effort to spur exports, collaboration in space, defence and information technology, will be the top priority of the Indian businesses and locals of the region who will meet at the forthcoming two-day India-LAC conclave in Chile next month from Oct 1. “The minister of State for external affairs Gen VK Singh who will participate along with a delegation in Santiago is expected to highlight the various initiatives of Prime Minister Narendra Modi’s government and seek new ventures in various sectors including agro-business, startups and space sector,” according to sources. Earlier, the minister of commerce and industry Suresh Prabhu was expected to lead a delegation for the conclave. He will now go to Brazil and Cuba in November. “There is a major ministerial-level participation from the region for the India LAC Conclave organised by the Ministry of External Affairs (MEA) & the Commerce and Industry Ministry and the United Nations Economic Commission for Latin America and the Caribbean (UNECLAC), with an industry body CII,” sources added. Anita Nayar, Indian ambassador to Chile told FE Online that, “The choice of Chile for the conclave is very strategic. It is also a signal that Indian businesses are looking towards Chile and vice versa.” Launch, of SUCHAI, the nano-satellite of the University of Chile, was successfully accomplished by Indian Space Research Organisation (ISRO) at the end of June 2017. The SUCHAI project is a standardized satellite of Cubesat type of 1 litre of volume and 1 kg of weight. It is the first satellite built in Chile by students at the university. The Chilean armed forces have expressed interest in buying the BrahMos missile a joint venture of India-Russia and there have been active discussions between the two sides. There have also been several queries from the government of Peru in the last few months, especially after the successful trials of the missile aboard the SU-30. The BrahMos Company is now registered with the government of Chile which will help in future sales in case negotiations culminate on a positive note. Also, as reported earlier there is a great opportunity for Indian defence companies to participate in the modernisation of Chilean armed forces, especially in the ship building, submarines and joint training. After a major slump in 2015 & 2016 due to impact of low copper price, both countries have hit record levels in 2017. The Indian auto makers including Telco and Mahindra have already entered the Chilean market, selling commercial vehicles, cars and two wheeler. India is also targeting the pharmaceutical market in Chile and is among the top 10 Indian exports to the country. Both countries are in discussions to finalise Phytosanitary requirements for the export of avocados, walnuts and blue berries from Chile and the import of mango, coco peat, and pomegranate from India, the Indian envoy added. The two countries in 2017 had operationalised the expanded India-Chile Preferential Trade Agreement (PTA) which also incorporates new chapters on Rules of Origin, Technical Barriers to Trade and Sanitary and Phytosanitary Measures, which would contribute to the reduction of non-tariff barriers. Source :- Financialexpress Background Music :- bensound.com Disclaimer- This channel is for defence related news worldwide . We try to give you true news related to each and every aspects of defence . It is either country, defence weapon, air Force, army ,navy, military or anything we will try to fully explain . The content specially news we upload are taken from various news channels and media houses . we never claim it is 100 % on our behalf but we try to deliver you exact without rumours . our news is specially related to india . As India is a growing country specially in defence under narendra modi BJP government . Channel Link: https://www.youtube.com/DefenceTube Facebook Link: https://www.facebook.com/defencetube Twitter Link : https://twitter.com/DefenceTube Check my all playlist : https://www.youtube.com/defencetube/playlist
Просмотров: 685 Defence Tube
Hedge Fund Manager Jeremy Grantham- Quant Trader with Event Driven Strategies
 
02:34
Jeremy Grantham is a British investor and co-founder and chief investment strategist of Grantham, Mayo, & van Otterloo (GMO), a Boston-based asset management firm. GMO is one of the largest managers of such funds in the world, having more than US$118 billion in assets under management as of March 2015. Grantham is regarded as a highly knowledgeable investor in various stock, bond, and commodity markets, and is particularly noted for his prediction of various bubbles. Event-driven strategies concern situations in which the underlying investment opportunity and risk are associated with an event. An event-driven investment strategy finds investment opportunities in corporate transactional events such as consolidations, acquisitions, recapitalizations, bankruptcies, and liquidations. Managers employing such a strategy capitalize on valuation inconsistencies in the market before or after such events, and take a position based on the predicted movement of the security or securities in question. Large institutional investors such as hedge funds are more likely to pursue event-driven investing strategies than traditional equity investors because they have the expertise and resources to analyze corporate transactional events for investment opportunities. Corporate transactional events generally fit into three categories: distressed securities, risk arbitrage, and special situations. Distressed securities include such events as restructurings, recapitalizations, and bankruptcies. A distressed securities investment strategy involves investing in the bonds or loans of companies facing bankruptcy or severe financial distress, when these bonds or loans are being traded at a discount to their value. Hedge fund managers pursuing the distressed debt investment strategy aim to capitalize on depressed bond prices. Hedge funds purchasing distressed debt may prevent those companies from going bankrupt, as such an acquisition deters foreclosure by banks. While event-driven investing in general tends to thrive during a bull market, distressed investing works best during a bear market. Risk arbitrage or merger arbitrage includes such events as mergers, acquisitions, liquidations, and hostile takeovers.[66] Risk arbitrage typically involves buying and selling the stocks of two or more merging companies to take advantage of market discrepancies between acquisition price and stock price. The risk element arises from the possibility that the merger or acquisition will not go ahead as planned; hedge fund managers will use research and analysis to determine if the event will take place. Special situations are events that impact the value of a company's stock, including the restructuring of a company or corporate transactions including spin-offs, share-buy-backs, security issuance/repurchase, asset sales, or other catalyst-oriented situations. To take advantage of special situations the hedge fund manager must identify an upcoming event that will increase or decrease the value of the company's equity and equity-related instruments. Other event-driven strategies include: credit arbitrage strategies, which focus on corporate fixed income securities; an activist strategy, where the fund takes large positions in companies and uses the ownership to participate in the management; a strategy based on predicting the final approval of new pharmaceutical drugs; and legal catalyst strategy, which specializes in companies involved in major lawsuits. FAIR USE NOTICE: This channel may make use of copyrighted material. This channel gains no profit from broadcasted content. In accordance with Title 17 U.S.C. Section 107, the material on this channel is offered publicly and without profit, to the public users of the internet for comment, non-profit, educational, and informational purpose. No copyright is claimed. This content is being posted here for financial educational purposes, so that investors will have a better understanding of financial markets.
Просмотров: 1561 scottab140
Retail Industry: Digital Transformation, Customer Experience, and Innovation (CXOTalk #282)
 
48:56
How is the retail industry changing and innovating? How about the role of customer experience and change agents? For more information and to read the complete transcript, see https://www.cxotalk.com/episode/digital-transformation-retail-innovation-changes Dana Randall, head of innovation at Tapestry, speaks with CXOTalk and guest co-host Brian Solis about digital transformation in retail businesses. The company, which includes the brands Coach and Kate Spade, is rethinking traditional sales and adapting to shifts in social, cultural, technology and consumer expectations. Dana Randall is the Head of Innovation at Tapestry, helping to drive innovation in retail through strategic partnerships with technology companies and startups. She has been listed by Digiday in The Glossy 50 recognizing the leaders creating change in fashion, luxury, beauty, and tech, as well as named as one of Brand Innovators 40 Under 40 & Women to Watch.
Просмотров: 6383 CXOTALK
PPCChamp Client Review - "We Made over 3.5 Crore in Sales" -  Sahil Sharma MD at JM Healthcare
 
01:56
Sahil Sharma is the Director of JM Healthcare Pvt. Ltd. - A Reputed Third Party Pharma Manufacturing Company based in Chandigarh. In this video one of our Clients Mr Sahil Sharma shared his words of appreciation with us after we successfully delivered digital marketing services. Looking for the Best Digital Marketing Agency in India for your business then look no further than PPCChamp as we can help you with all your Digital Marketing, Social Media Marketing, SEO related activities etc. Contact Details: PPCChamp – Digital Marketing Company Address: Building Number- 54-55, Sector 34 A Chandigarh India -160022 Phone Number: +91-9501488575, +91-9878873077 Email: Info@ppcchamp.com Website: http://www.ppcchamp.in/ Skype: PPC.Champ
Просмотров: 339 PPCChamp Digital Marketing Company
When To Stop Taking Cholesterol & Blood Thinning Medication? ArteryCleanze.com
 
02:29
When To Stop Taking Cholesterol & Blood Thinning Medication? ArteryCleanze.com https://arterycleanze.com/sales/ To Those Who Are Are On Drugs & Want To STOP Taking Drugs Right Away, Please read this... Many ArteryCleanze users who are on blood thinning" (anticoagulant) drug such as Aspirin, Plavix, Warfarin/Coumadin, etc... wrote to us asking if they can STOP taking drugs right away, because they would rather use something natural and they are tired of the negative effects. Legally and ethically, we cannot tell you to stop using your drug and you should always first speak to your doctor before making any changes to your current medications and dosages. However, below are some things to consider... What Other Users Have Done Over the years we've had hundreds and thousands of people report back to us the success they've had by using ArteryCleanze™ instead of their prescription drug or in addition to, while lowering the dosage of their drug. Either way, the end result is less drugs and negative side-effects. With that said, here's what other users have reported back to us: Start using ArteryCleaze™ slowly with 2 capsules a day after breakfast Slowly lower your prescription drug (but don't get off) Depending on your dosage and duration, you'll should slowly lower your drug dosage. The higher the dose, the longer the duration, the more time needed to lower the dosage. For example, if you are taking 75 mgs of Plavix daily for 10 years (which is an average dose and long duration), then you'll need to take a 4-6 months to SLOWLY lower the the dose. Versus if you've been on half the dose for only 3 months... which is a lower dose and you can probably just get off quicker in about 3-4 months So, it's very difficult to give specific advice here. Needless to say, slowly lower the dosage over the next few weeks, but don't get off completely. Lower the dose to about HALF and then do another blood test in 3-6 months. If your numbers are good, then take another 1-2 months and cycle OFF the drug. WARNING: "Rebound" Effect One reason you don't want to just get off a drug completely or quickly is because these drugs are "addictive" to the body and will cause a negative "rebound" effect and can cause circulatory problems. Using ArteryCleanze™ will help, but it can only do so much. That's why we've emphasized "slowly". Once again, you should always FIRST consult with your doctor when making any changes to your current medications.
Nutraceuticals - Product Packaging Date Code Printing and Lot Coding
 
02:03
See how Nutraceuticals Market uses the Handheld Printer to solve Inkjet Date Coding and Lot Code printing on Product Packaging. Now Packaging Manufacturers of Nutraceuticals can easily print Date Codes and Batch Lot Numbers, without the need for expensive and complex equipment found in Inline Inkjet Printers. JetStamp 790MP Handheld Date Coding Printer Handheld Inkjet in a printer that offers a self-traversing print head. Small Character printing, in two lines. Quick-Dry Ink Colors: Black or Yellow Jetstamp 970 Handheld Printer The latest Reiner JetStamp Printer, the model 970, provides for multiple print lines and High Resolution printing of Text, Barcode or Graphics. For any Nutraceuticals Inkjet Coding Solutions. Partner with us for a Handheld Inkjet Printer. Visit http://inkjetcodingandmarking.com/store/category/reiner-inkjet-jetstamps/ or Call: 409.838.5391
Просмотров: 189 Inkjet Coding and Marking
How to Track Serialized Products with Unleashed Software
 
10:37
Reuben Sweeney demonstrates how to track serialized products both in-to, and out-of your warehouse. If you deal with high-value components or end-products then this session is for you. Using Unleashed Inventory we can individually track the unique serial numbers on each item as they arrive in our warehouse and as they leave to ensure every unit is accounted for. This allows us to better manage warranty returns and repairs as we can track the initial sale and subsequent warranty claims on unique units. Our industry-specific mastery courses take you through getting the most out of your Unleashed by providing the best practices, tips and reports for your industry. https://www.linkacademy.com/unleashed/ We'll answer any questions you have about Inventory Management, Manufacturing, Unleashed or Xero in the comments below. If you're rather ask us in person, follow the link below to book a time that suits you straight into our calendar: https://calendly.com/link-academy-team/i-have-a-quick-question
Просмотров: 714 Link Academy
FlipKart & Amazonக்கு புதிய கட்டுப்பாடுகள் - New rules for e-commerce Websites in India
 
03:05
FlipKart & Amazon Discounts and offers 2019 - Indian government announced new e-commerce rules restricting.Flipkart and Amazon from sourcing in excess of 25 percent of their stock from a single seller - huge numbers of them in which these retailing giants hold stakes. More Details : http://bit.ly/2LDEFKn Buy DEM Trends Tshirts at 50% Offers : Amazon : https://amzn.to/2w3lbIy FlipKart : http://bit.ly/2OUTOHt Snapdeal : http://bit.ly/2NaxrNO Follow us : Whatsapp : https://goo.gl/Fyf6gQ Instagram : https://www.instagram.com/red_tech_tamizha Google + : https://plus.google.com/+RedTechTamizha Facebook : https://www.facebook.com/redtechtamizha Twitter : https://twitter.com/redtechtamizha Official Red Tech தமிழா Websites websites : http://www.rtt24x7.com websites : http://www.rtt24x7tamil.com இது போல இன்னும் பல வீடியோ உங்கள்ளுக்காக . SUBSCRIBE செய்யவும் . Youtube : https://www.youtube.com/c/Redtechthamizha
Просмотров: 293 Red Tech Tamizha
Tilray: The next steps for pot in Canada?
 
02:16
Located on an industrial strip of land that juts into the harbour in scenic Nanaimo, B.C., Tilray is one of 35 companies in Canada licenced by the federal government to produce medicinal marijuana that can be mailed to patients with prescriptions.
Просмотров: 119 Vancouver Sun
Future Of NMDC, Lupin, Cipla, Future Cons | Your Stocks | CNBC TV18
 
11:34
In this episode of Your Stocks, market experts - Mayuresh Joshi & Rajat Bose - share their views on the future NMDC, Lupin, Cipla, Future Cons. CNBC-TV18 is India's No.1 Business medium and the undisputed leader in business news. The channel's benchmark coverage extends from corporate news, financial markets coverage, expert perspective on investing and management to industry verticals and beyond. CNBC-TV18 has been constantly innovating with new genres of programming that helps make business more relevant to different constituencies across India. India's most able business audience consumes CNBC-TV18 for their information & investing needs. This audience is highly diversified at one level comprising of key groups such as business leaders, professionals, retail investors, brokers and traders, intermediaries, self-employed professionals, High Net Worth individuals, students and even homemakers but shares a distinct commonality in terms of their spirit of enterprise. Subscribe to our Channel: https://goo.gl/hKwgtm Like us on Facebook: https://www.facebook.com/cnbctv18india/ Follow us on Twitter: https://twitter.com/CNBCTV18News Website: http://www.moneycontrol.com/cnbctv18/
Просмотров: 1502 CNBC-TV18
School Fundraising With Symposium
 
03:22
Fundraise with Symposium. https://www.Symposium.us Fundraising in today’s educational system is both challenging and necessary. Schools and clubs experience mixed results by selling everything from candy and candles to t-shirts. Symposium provides a fundraising solution that gives parents and relatives a product more valuable than anything tangible; real-time participation in the memorable moments of their young student’s life while preserving a digital copy for a lifetime of memories. With the SymCast feature on the Symposium App, an organization can sell a pay-per-view live stream broadcast as well as sell a digital recording of the event, all at their desired price. Examples of different types of SymCast events relevant to the educational system include: Graduation Ceremonies Senior Awards Nights Holiday Recitals Theatrical Plays Orchestra, Choir and Band Performances Sporting Events Council Meetings Debates etc. What are the Advantages of using Symposium? • It’s Free! There is no charge to download the app or create a listing for an event. • No personal phone numbers, emails, or credit card information is required to be shared between users. • No need to worry about credit card fees, chargebacks or separate third-party transactions - All transactions are conducted directly through Symposium’s secured system! • Create and schedule based on your time and to your availability. • Choose your own price. You decide how much money you want to raise! • Promote your listing on your Socials using Symposium’s state of the art sharing system. • Every SymCast is recorded and can be sold. Multiply your fundraising ability! • Hosting can be done with a laptop, complex camera equipment, or a simple smartphone. Symposium Features: List your price, available times and duration of your event for any of the following: SymTalk : 1-to-1 scheduled video chat sessions. Perfect for tutoring students or explaining lessons to parents so they can better help with homework. Each teacher can raise money for their class individually. All sessions are monitored, recorded and available for purchase. SymCast : 1-to-many scheduled pay-per-view live stream and digital recordings. Broadcast your live performance or event on a pay-per-view platform then, sell the digital recording effortlessly through the app. Family and friends alike want to be part of the student’s special moments as they happen; Symposium gets you there today, preserves memories for tomorrow and raises money for your school. SymGram : Personalized recorded video messages. Know a celebrity? Perfect for celebrities of all types. Send out recorded birthday messages, graduation congrats, or just well wishes to fans and followers. START FUNDRAISING TODAY! Available in the App Store, Google Play, and Symposium.us, Symposium gives schools and organizations a new way to fundraise that captures and preserves the special moments of a student’s life. Apple Store: https://itunes.apple.com/us/app/symposium-marketplace/id1261760333?mt=8 Google Play: https://play.google.com/store/apps/details?id=us.symposium.app Web App: https://app.symposium.us If you have any questions, please contact Kirk Johnson 702 343-7633 or email Kjohnson@symposium.us SYMPOSIUM ONE SHEET: https://s3-us-west-1.amazonaws.com/symposiumcorp/Fundraise+with+Symposium+Marketplace+.pdf
Просмотров: 13990 Symposium App
How To Get Referrals From Closed Hospital Systems
 
10:31
"We exist to help service providers find those in need of care. Our ultimate goal is to help these providers increase their census, revenue, and PROFITS." Go to www.HomeCareMarketing.net to learn more or call us today at 848-444-9865. Having trouble getting into hospitals? You should probably just give up, right? WRONG! In this week's episode of A Drink with "The Hurricane," Steve discusses how to get referrals from hospitals even when they tell you no soliciting.  Video Transcript Dramatizations are my favorite type of Drink With a Hurricanes to do because I get a chance to show you what is happening and when everyday people watch dramatizations they're like man that happened just last week or how did you know. Trust me, I've been there. I've done it and I'm working with hundreds of people all around the world on their home care businesses. It happens everywhere. Closed hospital systems are the best referrals source that we could ever have but they are by far the most difficult to get into. And I don't have 90 minutes to go over how to get into a hospital on this episode of A Drink With the Hurricane. But what I am gonna say is because these closed hospital systems are everywhere, I want to put into realistic expectations just how long and how much effort it takes to develop a hospital. And also understand the reason why most people don't. So first and foremost, because a hospital has so much volume of patients, and every person in the hospital has a great need, everybody wants to get business from the hospital. Not just home care! Everybody is trying including assisted living, the pharmaceutical companies, medical device sales, home health companies, hospice companies, skilled nursing facilities, and the CCRCs. I mean everybody is trying to get business from the hospitals. By, in theory, a hospital supports like a hundred different businesses with the amount of volume that a hospital does business with. So every day, every company in the area, I mean even you yourselves, you are probably within 10 miles, maybe 15 miles from a hospital. Because when people go to the hospital and they come home they're going to need your services. So it makes sense that a hospital is the mecca it is the top of the food chain of all of the referrals in our community because people start there and then it filters through to everybody else. So logically it makes sense. Now because of that, they're the pinnacle and everybody else underneath there in the healthcare continuum in our area is all trying to get in there, they all have this policy if you can't come here and market because if they allowed people to come in and market every day 100, 200 marketing representatives, would show up canvassing for business. That's why they have the no-solicitation policy. That's why you can't get in there. That's why it's so hard to get in there. But you want to know something that's really interesting for my clients who get into hospitals? When you actually get into a hospital those caseworkers, those social workers in the emergency department, in the cardiology department, in the oncology department, or the neurology department, those specific, or orthopedic, those specific units that I'm just mentioning, they always say I had no idea you existed. No one ever comes here and tells us about this. Yeah, we'll give you referrals. And that's why we continue to go. That's why we got to go there again and again and again and again. Read more at https://homecaremarketing.net/how-to-get-referrals-from-closed-hospital-systems/
Просмотров: 926 Home Care Marketing by HME
3 STOCKS TO BUY APRIL 2018
 
09:41
3 Stocks to Buy in April 2018 is a popular series on this channel. I cover stocks to watch, buy, invest in April 2018! These are 3 stocks you can buy today, and hold forever on the dip as they are currently presenting great opportunities for entries. The 3 picks for this month are Nvidia Stock, Facebook Stock, and Home Depot Stock. All 3 of these companies have had a great 2017, and have recently been experiencing some turbulence but I believe they will make a good recovery in 2018. 1) Nvidia Stock Analysis NVDA These guys are just a profit machine and growth machine and they keep posting outstanding numbers and show no signs of slowing down. The last month or so as the market has been a bit weak and volatile, NVDA has kind stood its ground. Everytime it sells off, buyers come back in to push it higher. This stock is really outperforming the market right now, and is showing similar strength as AMZN and NFLX as well. In march, we had 2 analysts come out and reiterate their view on NVDA this month. Both have targets that are a lot higher than the current share price and it's clear analysts are also very bullish on NVDA's future. If you want to see my technical analysis and view on Nvidia, check out the video. 2) Facebook Stock Analysis FB You guys already know my stance on FB - this is a stock I personally hold in my long term portfolio, and it's a company that just keeps growing. They own FB, Insta, and WHatsapp, and they have over 2B users on these platforms. Celebs are switching from Snap to Insta, which is where I think FB will be seeing a lot of $ coming in from. The selloff imo was unwarranted - I gave my reasoning in this video so check it out if you're unsure. I believe FB will recover this year - but April in a great time to scoop up more shares in this company. It might be a slower recovery than we're used to, but as long as their earnings and growth continue, it should be back to ATH this year. In march there was only 1 analyst who came out and reiterated their stance on Facebook. If you want to see my technical analysis and view on Nvidia, check out the video. 3) Home Depot Stock Analysis HD HD - of course a home improvement store, the largest in this space in North America - and their only true competitor is Lowes - who is far behind. Morgan Stanley said the recent weakness has created a "compelling entry point" for investors. You shouldn't believe what these Analysts say, but you should pay attention to the general sentiment. Nothing has fundamentally changed in HD and they are still strong, and MS recognizes that. There are fears out there that interest rate hikes may affect home sales and renovation sales - but this is something we'll have to wait and see about. We did have hikes in the past, and home sales just kept rising QoQ, so if the last few years tells us anything, it's that people want to buy houses! In March, Loop Capital initiated coverage on HD. If you want to see my technical analysis and view on Nvidia, check out the video. Thank you for watching! Don't forget to LIKE, COMMENT and SUBSCRIBE if you haven't done so already to support the channel - it means a lot to me! Let me know what videos you would like me to cover in the future. Either way, remember to invest positively. Peace! Disclaimer: None of the stocks, options, or securities that I discuss should be taken as advice or recommendations to buy/sell/hold as I am not a financial adviser. The views and information presented in these videos is strictly for educational purposes and I will not be held liable for your gains or losses incurred due to trading, investing, or getting involved in the stock market. Follow me on Twitter: https://goo.gl/w4xsnl Follow me on Instagram: https://goo.gl/fW5rYn Equipment used for videos: Microphone: http://amzn.to/2zVpWGz Lighting Kit: http://amzn.to/2EVbL8t Camera: http://amzn.to/2HPaqgT Laptop for Editing: http://amzn.to/2EUbORQ
Просмотров: 3347 Positive Investing
STOCK ANALYSIS OF ASHOK LEYLAND 400% RETURNS
 
04:26
SM Investor Be smart in Life For more such interesting and informative updates you can also connect to us on Facebook :- https://www.facebook.com/SMInvestor1 Twitter :- https://twitter.com/sm_investor WhatsApp group: https://chat.whatsapp.com/8JzShVIapOq5PRRpOnpLM4 This Channel Covers Various Stocks/Share/Pick/Tips,Sector,IPO,Experts,etc. see below for details. Stocks Covered: Nifty 50 Stocks: Tata Consultancy Services Ltd.(TCS),Reliance Industries Ltd.(RIL),HDFC Bank Ltd.,ITC Ltd., Hindustan Unilever Ltd.(HUL),Housing Development Finance Corporation Ltd.,Maruti Suzuki India Ltd., Infosys Ltd.,Oil & Natural Gas Corporation Ltd.(ONGC),Kotak Mahindra Bank Ltd.,State Bank Of India(SBI), Larsen & Toubro Ltd.(L&T), Coal India Ltd., ICICI Bank Ltd., Bharti Airtel Ltd., Indian Oil Corporation Ltd.(IOC), HCL Technologies Ltd., NTPC Ltd., Wipro Ltd., Axis Bank Ltd., Sun Pharmaceutical Industries Ltd., Vedanta Ltd., Ultratech Cement Ltd., Asian Paints Ltd., Indusind Bank Ltd., Bajaj Finance Ltd., Power Grid Corporation Of India Ltd., Mahindra & Mahindra Ltd.(M&M), Tata Motors Ltd., Eicher Motors Ltd., Titan Company Ltd., Bajaj Finserv Ltd., Bajaj Auto Ltd., Bharat Petroleum Corporation Ltd.(BPCL), Adani Ports and Special Economic Zone Ltd., Hero motocorp Ltd., GAIL (India) Ltd., Tata Steel Ltd., Grasim Industries Ltd., Yes Bank Ltd., Tech Mahindra Ltd., Bharti Infratel Ltd., Hindalco Industries Ltd., Indiabulls Housing Finance Ltd., Zee Entertainment Enterprises Ltd., Cipla Ltd., Hindustan Petroleum Corporation Ltd.(HPCL), UPL Ltd., Lupin Ltd., Dr. Reddys Laboratories Ltd. Other stocks Covered: Dewan Housing (DHFL), Advance Enzymes, CDSL, MCX, ION Exchange, Greenply, NBCC, Godrej Agrovet, Cochin Shipyard, Sterlite Technologies, Natco Pharma, GSFC, Tata Chemicals, Ashok Leyland, Aditya Birla Capital(AB Capital), Karnataka Bank, Thomas Cook, KEC International, SCI, Uflex, Capital First, ICICI Prudential, ICICI Lombard, HDFC Life, SBI Life, Bharat Dynamics, HAL, DMART(Avenue Supermart), BSE, Bandhan Bank, Sandhar Tech, Amara Raja Batt, CARE, GIC, Force Motors, Sintex Plastics, Sintex Ind, Galaxy Surfactant, Mishra Dhatu, PC Jewelers, Fortis Healthcare, Suzlon Energy, CEAT, Idea Cellular, Titan, Bata India, Mindtree, MRF, Dabur India, Astec Lifesciences, Ruchi Soya, Bhushan Steel, Jaypee Infra, Gitanjali Gems, Kwality, Century Textile, Bliss GVS Pharma, IOL Chemicals & Pharma Sector Covered: Financials, Utilities, Consumer, Energy, Healthcare, Industrials, Technology, Telecom, Real Estate, Automotive, Auto - 2 & 3 Wheelers, Cement & Construction, Chemicals, Engineering & Capital Goods, Food & Beverages, Manufacturing, Media & Entertainment, Metals & Mining, Oil & Gas, Tobacco Type of Stocks Covered: Large cap, Mid cap, Small Cap, Multibagger, Penny, High Return, High Growth, Blue Chip Share, Debtfree, Dividend Yielding, Strong Fundamental, Profitable Business/Company Types of Trading: Intraday, Long term, Mid term, Short term, Swing Trading, F&O, IPO, Type of Calls: Jackpot, Multibagger, Value Pick, Top Recommendations, Crorepati Stocks, Latest Call Terms Covered: Candlestick Patterns, Health, Insurance, Premium, Claim, Home, Loan, Interest, Delivery Percentage, Case Study, RHP, DRHP, MACD, Candle, Gap up, Gap down, Subscribe, FII, NII, QIB, Allotment, Check, KYC, Know your company, Listing Gain, Balance Sheet, Profit & Loss, Target, Price, Bonus, Dividend, Split, Buyback, OFS, IPO, Results Q1, Q2, Q3, Q4, QoQ, YoY, Demerger, Merger Mutual Fund: Holding, Types of Mutual Fund, Best Performing MF, Worst Performing MF Channel/Site Covered: Zee Business, CNBC Awaaz, Money Control Shows Covered: Stock Fatafat Sauda Aapka, Kal Ka Bazaar, Bazaar Agle Hafte, Value Pick Kal Ka Bazaar, Market ka Punchnama Expert Covered: DD sharma, SP Tulsian, Rakesh Jhunjhunwala, Anil Singhvi, Radhakrishna Damani, Raamdeo Agarwal, TS Harihar, Sidharth Sedani, Mehraboon Irani, VK Sharma, Kunal Saraogi, Avinash Gorakshkar, Ramesh Damani, Parag Parikh, Chandrakant Sampat, Chandresh Nigam, Chaitanya Dalmia, Ashish Dhawan, Sanjay Bakshi, Samir Arora, Saurabh Mukherjea, Anoop Bhaskar, Ridham Desai, Ashwani Gujral, Sudarshan Sukhani, Prakash Gaba, Porinju Veliyath, Sandeep Jain, Dolly Khanna, Sudip Bandyopadhyay, Vijay Chopra, Sandip Jain, Sandeep Jain, Rakesh Bansal, Simi Bhaumik Broker Covered: Motilal Oswal, IIFL, Share khan, Kotak Securities, HDFC Securities, ICICI Securities, Axis Direct, Edelweiss, Geojit, Dolat Capital, Prabhudas Lilladher, Nomura, Jefferies, Languages: English, Hindi, Gujarati Date: 01, 02, 03, 04, 05, 06, 07, 08, 09, 10, 11 ,12, 13, 4, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30,31 Month: January, February, March, April, May, June, July, August, September, October, November, December Year: 2017,2018,2019,2020
Просмотров: 3387 SM Investor
Surging Oil Prices Are Deteriorating Macros, Says Prabhudas Lilladher | CNBC TV18
 
05:18
Ajay Bodke, Prabhudas Lilladher, discusses with Prashant Nair and Ekta Batra his analysis on the fundamental side of the market as well as specific stocks and sectors. Bodke said that macros are deteriorating because of the surging global crude oil prices and he is expecting the Reserve Bank of India (RBI) to act soon and increase interest rates. He said, "The improvement in micros at the take off in corporate earnings is a tad slower than what the market factored in and that is why there is a feeling that the correction, that one is seeing, should continue for some time.” Bodke is expecting market to test levels of 10,300 to 10,400 in the short term. CNBC-TV18 is India's No.1 Business medium and the undisputed leader in business news. The channel's benchmark coverage extends from corporate news, financial markets coverage, expert perspective on investing and management to industry verticals and beyond. CNBC-TV18 has been constantly innovating with new genres of programming that helps make business more relevant to different constituencies across India. India's most able business audience consumes CNBC-TV18 for their information & investing needs. This audience is highly diversified at one level comprising of key groups such as business leaders, professionals, retail investors, brokers and traders, intermediaries, self-employed professionals, High Net Worth individuals, students and even homemakers but shares a distinct commonality in terms of their spirit of enterprise. Subscribe to our Channel: https://goo.gl/hKwgtm Like us on Facebook: https://www.facebook.com/cnbctv18india/ Follow us on Twitter: https://twitter.com/CNBCTV18News Website: http://www.moneycontrol.com/cnbctv18/
Просмотров: 183 CNBC-TV18
Left Behind America
 
52:09
The documentary is subtitled, incl. the Chinese speaking parts. Turn on subtitles. - Dayton, located in Ohio in the US rust belt, was once a thriving city, the center of both industry and aviation, but is now fighting for 10 years with the aftermath of the financial crisis. Workplaces are closed and those who are left are so poorly paid that 35 percent of the city's population now lives below the poverty line. American documentary from 2018. FRONTLINE and ProPublica report on the economic and social forces shaping Dayton. Director: Shimon Dotan Writer: Shimon Dotan (written, produced and directed by)
Просмотров: 69250 AvapXia
Crushing It with Messenger Chat Bot Marketing Expert | Niel Reichl | FBP 151
 
01:22:04
A combination of relentless drive and plenty of hard work turned unfortunate events into opportunities for our FBP 151 guest. This guy with an easy demeanor and bright outlook has also proved himself to be resilient and a fast learner. In 3 years, Neil Reichl has turned from a pharmaceutical sales rep to a ChatBot marketing expert. All the long drives that he made while listening to podcasts when he was still a sales rep turned out to be the training ground for his digital marketing and freelancing career. WHY CHATBOT MARKETING? An early adopter of ChatBot marketing, Neil recognized the need for a more effective way of getting leads and engaging with old both old and potential customers. With an even tougher competition now as all types of media are clamoring for a person’s already short attention span, how does a business get their voice heard loud and clear? With email marketing effectivity slowly dropping (25% open rate, 3% CTR), Neil saw how more people, regardless of age or status, are now more likely to use Facebook Messenger as their main means of communication. It is not surprising that statistics for Facebook Messenger Marketing campaigns show an 89% open rate with a 50-60% CTR. For instance, the reach can be greater too as people who may not follow or “like” your page can still send you a message and contact you on Facebook. Are you as interested as I am now? I too believe that ChatBot marketing is the next big thing so I signed up for Neil’s ChatBot marketing premium course to learn more about it. If you want to see a ChatBot in action, watch the FBP 151 video to see a demo of how a ChatBot can bring in more leads and convert fans into paying customers. KEY HIGHLIGHTS FBP 151 comes with loads of useful tips from Neil. Also, you will get the chance to see us in our formal wear! QUOTES Neil on how to effectively use ChatBots: “Courtesy should always be your first step” Marv on taking new challenges from clients: “Say yes and learn it.” Neil on avoiding analysis paralysis: “Take action!” LINKS - See a ChatBot in action here: http://bit.ly/chatbotMarv - ManyChat.com - Do you want to get more tips for fellow freelancers? Join us on Facebook and connect with hundreds of Filipino freelancers! https://www.freelanceblenders.com
Просмотров: 57 FreelanceBlend